Activation of necroptosis in multiple sclerosis

Cell Reports

Volumn 10, Issue 11, 2015, Pages 1836-1849

  Ofengeim, Dimitry ^a   Ito, Yasushi ^a   Najafov, Ayaz ^a   Zhang, Yaoyang ^b   Shan, Bing ^b   DeWitt, JudyPark ^a   Ye, Juanying ^e   Zhang, Xumin ^e   Chang, Ansi ^b   Vakifahmetoglu Norberg, Helin ^a,f   Geng, Jiefei ^a   Py, Benedicte ^a   Zhou, Wen ^a   Amin, Palak ^a   Lima, JonilsonBerlink ^a   Qi, Chunting ^c   Yu, Qiang ^c   Trapp, Bruce ^d   Yuan, Junying ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d LERNER RESEARCH INSTITUTE   (United States)

^e FUDAN UNIVERSITY   (China)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CUPRIZONE; MIXED LINEAGE KINASE DOMAIN LIKE PROTEIN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MLKL PROTEIN, HUMAN; PROTEOME; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; TUMOR NECROSIS FACTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IN VITRO STUDY; LEWY BODY; MOUSE; MULTIPLE SCLEROSIS; NECROPTOSIS; NERVE CELL DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; OLIGOMERIZATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN MISFOLDING; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; WHITE MATTER LESION; ANIMAL; BRAIN CORTEX; C57BL MOUSE; DRUG EFFECTS; GENETICS; METABOLISM; NECROSIS; PATHOLOGY; SPINAL CORD;

ANIMALIA;

ANIMALS; APOPTOSIS; CASPASE 8; CEREBRAL CORTEX; HUMANS; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; NECROSIS; OLIGODENDROGLIA; PROTEIN KINASES; PROTEOME; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925677956     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.02.051     Document Type: Article

References (49)

1. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351:602-611.
2. Arnett H.A., Fancy S.P., Alberta J.A., Zhao C., Plant S.R., Kaing S., Raine C.S., Rowitch D.H., Franklin R.J., Stiles C.D. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 2004, 306:2111-2115.
3. Berger S.B., Kasparcova V., Hoffman S., Swift B., Dare L., Schaeffer M., Capriotti C., Cook M., Finger J., Hughes-Earle A., et al. Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J.Immunol. 2014, 192:5476-5480.
4. Blakemore W.F. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J.Neurocytol. 1972, 1:413-426.
5. Buck D., Hemmer B. Treatment of multiple sclerosis: current concepts and future perspectives. J.Neurol. 2011, 258:1747-1762.
6. Buschmann J.P., Berger K., Awad H., Clarner T., Beyer C., Kipp M. Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination. J.Mol. Neurosci. 2012, 48:66-76.
7. Butts B.D., Houde C., Mehmet H. Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease. Cell Death Differ. 2008, 15:1178-1186.
8. Cai Z., Jitkaew S., Zhao J., Chiang H.C., Choksi S., Liu J., Ward Y., Wu L.G., Liu Z.G. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 2014, 16:55-65.
9. Chen X., Li W., Ren J., Huang D., He W.T., Song Y., Yang C., Li W., Zheng X., Chen P., Han J. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 2014, 24:105-121.
10. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M., Chan F.K. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
11. Christofferson D.E., Li Y., Hitomi J., Zhou W., Upperman C., Zhu H., Gerber S.A., Gygi S., Yuan J. A novel role for RIP1 kinase in mediating TNFα production. Cell Death Dis. 2012, 3:e320.
12. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., Cuny G.D., Mitchison T.J., Moskowitz M.A., Yuan J. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 2005, 1:112-119.
13. Degterev A., Hitomi J., Germscheid M., Ch'en I.L., Korkina O., Teng X., Abbott D., Cuny G.D., Yuan C., Wagner G., et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 2008, 4:313-321.
14. Dondelinger Y., Declercq W., Montessuit S., Roelandt R., Goncalves A., Bruggeman I., Hulpiau P., Weber K., Sehon C.A., Marquis R.W., et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 2014, 7:971-981.
15. Eugster H.P., Frei K., Bachmann R., Bluethmann H., Lassmann H., Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 1999, 29:626-632.
16. Griffith J.W., Luster A.D. Targeting cells in motion: migrating toward improved therapies. Eur. J. Immunol. 2013, 43:1430-1435.
17. He W., Lu Y., Qahwash I., Hu X.Y., Chang A., Yan R. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat. Med. 2004, 10:959-965.
18. He S., Wang L., Miao L., Wang T., Du F., Zhao L., Wang X. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100-1111.
19. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., Xavier R.J., Yuan J. Identification of a molecular signaling network that regulates acellular necrotic cell death pathway. Cell 2008, 135:1311-1323.
20. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.L., Schneider P., Seed B., Tschopp J. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 2000, 1:489-495.
21. Holmes B.B., Furman J.L., Mahan T.E., Yamasaki T.R., Mirbaha H., Eades W.C., Belaygorod L., Cairns N.J., Holtzman D.M., Diamond M.I. Proteopathic tau seeding predicts tauopathy invivo. Proc. Natl. Acad. Sci. USA 2014, 111:E4376-E4385.
22. Jouan-Lanhouet S., Riquet F., Duprez L., Vanden Berghe T., Takahashi N., Vandenabeele P. Necroptosis, invivo detection in experimental disease models. Semin. Cell Dev. Biol. 2014, 35:2-13.
23. Jurewicz A., Matysiak M., Tybor K., Kilianek L., Raine C.S., Selmaj K. Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain 2005, 128:2675-2688.
24. Kaiser W.J., Upton J.W., Long A.B., Livingston-Rosanoff D., Daley-Bauer L.P., Hakem R., Caspary T., Mocarski E.S. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471:368-372.
25. Kawahara A., Ohsawa Y., Matsumura H., Uchiyama Y., Nagata S. Caspase-independent cell killing by Fas-associated protein with death domain. J.Cell Biol. 1998, 143:1353-1360.
26. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489.
27. Kayed R., Head E., Sarsoza F., Saing T., Cotman C.W., Necula M., Margol L., Wu J., Breydo L., Thompson J.L., et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2007, 2:18.
28. Kim S.J., Li J. Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia. Cell Death Dis. 2013, 4:e716.
29. Krueger A., Schmitz I., Baumann S., Krammer P.H., Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J.Biol. Chem. 2001, 276:20633-20640.
30. Li J., McQuade T., Siemer A.B., Napetschnig J., Moriwaki K., Hsiao Y.S., Damko E., Moquin D., Walz T., McDermott A., et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 2012, 150:339-350.
31. Luk K.C., Song C., O'Brien P., Stieber A., Branch J.R., Brunden K.R., Trojanowski J.Q., Lee V.M. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. USA 2009, 106:20051-20056.
32. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
33. Mycko M.P., Papoian R., Boschert U., Raine C.S., Selmaj K.W. Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Clin. Neurol. Neurosurg. 2004, 106:223-229.
34. Newton K., Sun X., Dixit V.M. Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol. 2004, 24:1464-1469.
35. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., Hakem R., Salvesen G.S., Green D.R. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
36. Ofengeim D., Yuan J. Regulation of RIP1 kinase signalling at thecrossroads of inflammation and cell death. Nat. Rev. Mol. Cell Biol. 2013, 14:727-736.
37. Sánchez I., Mahlke C., Yuan J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 2003, 421:373-379.
38. Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage invitro. Ann. Neurol. 1988, 23:339-346.
39. Sharief M.K., Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N.Engl. J. Med. 1991, 325:467-472.
40. Shorter J., Lindquist S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 2004, 304:1793-1797.
41. Spirig T., Ovchinnikova O., Vagt T., Glockshuber R. Direct evidence for self-propagation of different amyloid-β fibril conformations. Neurodegener. Dis. 2014, 14:151-159.
42. Sun L., Wang H., Wang Z., He S., Chen S., Liao D., Wang L., Yan J., Liu W., Lei X., Wang X. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012, 148:213-227.
43. Trapp B.D., Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 2008, 31:247-269.
44. Virtanen J.O., Jacobson S. Viruses and multiple sclerosis. CNS Neurol. Disord. Drug Targets 2012, 11:528-544.
45. Wallach D., Kang T.B., Yang S.H., Kovalenko A. The invivo significance of necroptosis: lessons from exploration of caspase-8 function. Cytokine Growth Factor Rev. 2014, 25:157-165.
46. Wang H., Sun L., Su L., Rizo J., Liu L., Wang L.F., Wang F.S., Wang X. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 2014, 54:133-146.
47. Zhang H., Zhou X., McQuade T., Li J., Chan F.K., Zhang J. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011, 471:373-376.
48. Zhang J., Zhang H., Li J., Rosenberg S., Zhang E.C., Zhou X., Qin F., Farabaugh M. RIP1-mediated regulation of lymphocyte survival and death responses. Immunol. Res. 2011, 51:227-236.
49. Zhang Y., Chen K., Sloan S.A., Bennett M.L., Scholze A.R., O'Keeffe S., Phatnani H.P., Guarnieri P., Caneda C., Ruderisch N., et al. AnRNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J.Neurosci. 2014, 34:11929-11947.